Westlake BioPartners Fund I, L.P.
CIK: 0001749591
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 10, 2026LTGO
Latigo Biotherapeutics, Inc.
Conversion(C)Indirect939K shares- - Aug 10, 2026LTGO
Latigo Biotherapeutics, Inc.
Conversion(C)Indirect3.5M shares- - Aug 10, 2026LTGO
Latigo Biotherapeutics, Inc.
Conversion(C)Indirect1M shares- - Aug 10, 2026LTGO
Latigo Biotherapeutics, Inc.
Conversion(C)Indirect3.5M shares- - Aug 10, 2026LTGO
Latigo Biotherapeutics, Inc.
Conversion(C)Indirect1.5M shares- - Aug 10, 2026LTGO
Latigo Biotherapeutics, Inc.
Conversion(C)Indirect165.5K shares- - Aug 10, 2026LTGO
Latigo Biotherapeutics, Inc.
Conversion(C)Indirect2.1M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 |  LTGO Latigo Biotherapeutics, Inc. | Conversion(C) | 938,979 | - | $0 | Indirect |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Conversion(C) | 3,547,842 | - | $0 | Indirect |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Conversion(C) | 1,027,635 | - | $0 | Indirect |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Conversion(C) | 3,464,072 | - | $0 | Indirect |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Conversion(C) | 1,484,401 | - | $0 | Indirect |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Conversion(C) | 165,519 | - | $0 | Indirect |
| Aug 10, 2026 | LTGO Latigo Biotherapeutics, Inc. | Conversion(C) | 2,066,857 | - | $0 | Indirect |
1-7 of 7 transactions
About Westlake BioPartners Fund I, L.P.
Westlake BioPartners Fund I, L.P. (SEC CIK 0001749591) files insider reports with the SEC as 10% Owner of Electra Therapeutics, Inc. (ETRA) and 10% Owner of Latigo Biotherapeutics, Inc. (LTGO).
Signal8 holds 3 ownership filings by Westlake BioPartners Fund I, L.P. (2 Form 3, 1 Form 4), filed between Aug 6, 2026 and Sep 21, 2026. Those filings report 7 transactions, the latest on Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Westlake BioPartners Fund I, L.P.'s filings is in WESTLAKE VILLAGE, CA.
Recent filings by Westlake BioPartners Fund I, L.P.
- Aug 10, 2026: Conversions of LTGO shares (7 lines, Form 4, code C).
Other insiders filing for Electra Therapeutics, Inc. (ETRA)
- GORDON CARL L, Director
- ORBIMED ADVISORS LLC, Director
- Koe Gary S., Chief Technical Officer
- Stagliano Nancy, Director
- Parry Graham, Principal Accounting Officer
- Dong Quehuong (Kathy), President & CEO